Philip Breitfeld

Philip Breitfeld

Director/Board Member chez CHAMPIONS ONCOLOGY, INC.

Fortune : 71 726 $ au 31/03/2024

71 ans
Consumer Services
Health Technology
Technology Services

Profil

Philip Breitfeld is the founder of The Breitfeld Group, LLC, which is founded in 2016, where he is currently the Managing Director.
He is also currently an Independent Director at Champions Oncology, Inc. since 2016 and the Chief Medical Officer at Allterum Therapeutics, Inc. since 2020.
Dr. Breitfeld's former positions include Vice President at IQVIA, Inc., Global Vice President at Quintiles, Inc. (California) from 2011 to 2015, and Associate Chief Medical Officer at BioCrystal Ltd.
from 2007 to 2009.
Dr. Breitfeld holds a doctorate from the University of Rochester and an undergraduate degree from Princeton University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
03/11/2023 14 638 ( 0,11% ) 71 726 $ 31/03/2024

Postes actifs de Philip Breitfeld

SociétésPosteDébut
CHAMPIONS ONCOLOGY, INC. Director/Board Member 11/04/2016
Chief Tech/Sci/R&D Officer 01/12/2020
Chief Executive Officer 01/01/2016
Tous les postes actifs de Philip Breitfeld

Anciens postes connus de Philip Breitfeld

SociétésPosteFin
Corporate Officer/Principal 01/12/2015
Corporate Officer/Principal 01/01/2009
IMS HEALTH, INC. Corporate Officer/Principal -
Voir l'expérience en détail de Philip Breitfeld

Formation de Philip Breitfeld

Rochester Christian University Doctorate Degree
Princeton University Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Philip Breitfeld

Relations

30

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
CHAMPIONS ONCOLOGY, INC.

Health Technology

Entreprise privées5

Technology Services

Health Services

Process Industries

Health Technology

Finance

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Philip Breitfeld